Metastatic Hormone and Her-2 Positive Breast Cancer: A Community Approach
Authors:
Open Access
- 13 June 2018
- journal article
- Published by Lupine Publishers LLC in Open Access Journal of Oncology and Medicine
- Vol. 2 (1) , 1-4
Abstract
Breast cancer is the most common cancer diagnosed globally as well as the most common cancer amongst women [1]. Approximately 6-10% of new breast cancer cases each year are initiallyKeywords
This publication has 4 references indexed in Scilit:
- Therapy targeted to the metastatic niche is effective in a model of stage IV breast cancerScientific Reports, 2017
- Alternative therapies for metastatic breast cancer: multimodal approach targeting tumor cell heterogeneityBreast Cancer: Targets and Therapy, 2017
- Chemotherapy principles of managing stage IV breast cancer in the United StatesChinese Clinical Oncology, 2016
- Dual HER2 blockade in the neoadjuvant and adjuvant treatment of HER2-positive breast cancerBreast Cancer: Targets and Therapy, 2015